{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T12:29:13Z","timestamp":1776947353020,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T00:00:00Z","timestamp":1266019200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1007\/s00280-010-1259-3","type":"journal-article","created":{"date-parts":[[2010,2,12]],"date-time":"2010-02-12T07:06:20Z","timestamp":1265958380000},"page":"1059-1063","source":"Crossref","is-referenced-by-count":27,"title":["Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma"],"prefix":"10.1007","volume":"66","author":[{"given":"Olivier","family":"Mir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislas","family":"Ropert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Babinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9rique","family":"Larousserie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Philippe","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Enkaoua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Anract","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,13]]},"reference":[{"key":"1259_CR1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2106\/00004623-197052030-00001","volume":"52","author":"RC Marcove","year":"1970","unstructured":"Marcove RC, Mike V, Hajek JV, Levin AG, Hutter RV (1970) Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. J Bone Jt Surg Am 52:411\u2013423","journal-title":"J Bone Jt Surg Am"},{"key":"1259_CR2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/1097-0142(197906)43:6<2163::AID-CNCR2820430602>3.0.CO;2-S","volume":"43","author":"G Rosen","year":"1979","unstructured":"Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG (1979) Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163\u20132177","journal-title":"Cancer"},{"key":"1259_CR3","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/S1470-2045(08)70309-7","volume":"9","author":"O Mir","year":"2008","unstructured":"Mir O, Ropert S, Goldwasser F (2008) Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma. Lancet Oncol 9:1198","journal-title":"Lancet Oncol"},{"key":"1259_CR4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1200\/JCO.1992.10.1.5","volume":"10","author":"PA Meyers","year":"1992","unstructured":"Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, Applewhite A, Vlamis V, Rosen G (1992) Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 10:5\u201315","journal-title":"J Clin Oncol"},{"key":"1259_CR5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1200\/JCO.1997.15.1.76","volume":"15","author":"AJ Provisor","year":"1997","unstructured":"Provisor AJ, Ettinger LJ, Nachman JB, Krailo MD, Makley JT, Yunis EJ, Huvos AG, Betcher DL, Baum ES, Kisker CT, Miser JS (1997) Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children\u2019s Cancer Group. J Clin Oncol 15:76\u201384","journal-title":"J Clin Oncol"},{"key":"1259_CR6","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1093\/clinchem\/42.8.1322","volume":"42","author":"SP Treon","year":"1996","unstructured":"Treon SP, Chabner BA (1996) Concepts in use of high-dose methotrexate therapy. Clin Chem 42:1322\u20131329","journal-title":"Clin Chem"},{"key":"1259_CR7","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1179\/joc.1996.8.6.472","volume":"8","author":"G Bacci","year":"1996","unstructured":"Bacci G, Ferrari S, Picci P, Zolezzi C, Gherlinzoni F, Iantorno D, Cazzola A (1996) Methotrexate serum concentration and histological response to multiagent primary chemotherapy for osteosarcoma of the limbs. J Chemother 8:472\u2013478","journal-title":"J Chemother"},{"key":"1259_CR8","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/1120009X.1990.11738996","volume":"2","author":"G Bacci","year":"1990","unstructured":"Bacci G, Picci P, Avella M, Dallari D, Ferrari S, Prasad R, Di Scioscio M, Malaguti C, Caldora P (1990) The importance of dose-intensity in neoadjuvant chemotherapy of osteosarcoma: a retrospective analysis of high-dose methotrexate, cisplatinum and adriamycin used preoperatively. J Chemother 2:127\u2013135","journal-title":"J Chemother"},{"key":"1259_CR9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/pbc.10443","volume":"42","author":"I Aquerreta","year":"2004","unstructured":"Aquerreta I, Aldaz A, Giraldez J, Sierrasesumaga L (2004) Methotrexate pharmacokinetics and survival in osteosarcoma. Pediatr Blood Cancer 42:52\u201358","journal-title":"Pediatr Blood Cancer"},{"key":"1259_CR10","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.1994.12.7.1443","volume":"12","author":"N Graf","year":"1994","unstructured":"Graf N, Winkler K, Betlemovic M, Fuchs N, Bode U (1994) Methotrexate pharmacokinetics and prognosis in osteosarcoma. J Clin Oncol 12:1443\u20131451","journal-title":"J Clin Oncol"},{"key":"1259_CR11","first-page":"289","volume":"83","author":"S Ferrari","year":"1992","unstructured":"Ferrari S, Orlandi M, Avella M, Caldora P, Ferraro A, Ravazzolo G, Bacci G (1992) Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate. Minerva Med 83:289\u2013293","journal-title":"Minerva Med"},{"key":"1259_CR12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00280-008-0772-0","volume":"63","author":"MR Green","year":"2009","unstructured":"Green MR, Chamberlain MC (2009) Renal dysfunction during and after high-dose methotrexate. Cancer Chemother Pharmacol 63:599\u2013604","journal-title":"Cancer Chemother Pharmacol"},{"key":"1259_CR13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF00548590","volume":"19","author":"TE Sand","year":"1981","unstructured":"Sand TE, Jacobsen S (1981) Effect of urine pH and flow on renal clearance of methotrexate. Eur J Clin Pharmacol 19:453\u2013456","journal-title":"Eur J Clin Pharmacol"},{"key":"1259_CR14","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.20255","volume":"100","author":"BC Widemann","year":"2004","unstructured":"Widemann BC, Balis FM, Kempf-Bielack B, Bielack S, Pratt CB, Ferrari S et al (2004) High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma. Cancer 100:2222\u20132232","journal-title":"Cancer"},{"key":"1259_CR15","first-page":"139","volume-title":"Cancer chemotherapy and biotherapy","author":"RA Messman","year":"2001","unstructured":"Messman RA, Allegra CJ (2001) Antifolates. In: Chabner BA, Longo DL (eds) Cancer chemotherapy and biotherapy. Lippincott Williams & Wilkins, Philadelphia, pp 139\u2013184"},{"key":"1259_CR16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1200\/JCO.1988.6.2.329","volume":"6","author":"K Winkler","year":"1988","unstructured":"Winkler K, Beron G, Delling G, Heise U, Kabisch H, Purf\u00fcrst C, Berger J, Ritter J, J\u00fcrgens H, Gerein V et al (1988) Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329\u2013337","journal-title":"J Clin Oncol"},{"key":"1259_CR17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1023\/A:1008391103132","volume":"9","author":"N Fuchs","year":"1998","unstructured":"Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, K\u00f6rholz D, Graf N, Heise U, J\u00fcrgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K (1998) Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group\u2019s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 9:893\u2013899","journal-title":"Ann Oncol"},{"key":"1259_CR18","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0959-8049(01)00229-5","volume":"37","author":"G Bacci","year":"2001","unstructured":"Bacci G, Briccoli A, Ferrari S, Longhi A, Mercuri M, Capanna R, Donati D, Lari S, Forni C, DePaolis M (2001) Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli\u2019s 4th protocol. Eur J Cancer 37:2030\u20132039","journal-title":"Eur J Cancer"},{"key":"1259_CR19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH (1976) Prediction of creatinine clearance from serum creatinine. Nephron 16:31\u201341","journal-title":"Nephron"},{"key":"1259_CR20","first-page":"1307","volume":"61","author":"L Norton","year":"1977","unstructured":"Norton L, Simon R (1977) Tumor size, sensitivity to therapy, and design of treatment schedules. Cancer Treat Rep 61:1307\u20131317","journal-title":"Cancer Treat Rep"},{"key":"1259_CR21","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/1120009X.1993.11739222","volume":"5","author":"S Ferrari","year":"1993","unstructured":"Ferrari S, Sassoli V, Orlandi M, Strazzari S, Puggioli C, Battistini A, Bacci G (1993) Serum methotrexate (MTX) concentrations and prognosis in patients with osteosarcoma of the extremities treated with a multidrug neoadjuvant regimen. J Chemother 5:135\u2013141","journal-title":"J Chemother"},{"key":"1259_CR22","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1080\/02841860510029770","volume":"44","author":"A Comandone","year":"2005","unstructured":"Comandone A, Passera R, Boglione A, Tagini V, Ferrari S, Cattel L (2005) High dose methotrexate in adult patients with osteosarcoma: clinical and pharmacokinetic results. Acta Oncol 44:406\u2013411","journal-title":"Acta Oncol"},{"key":"1259_CR23","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.ejca.2005.03.036","volume":"41","author":"G Bacci","year":"2005","unstructured":"Bacci G, Mercuri M, Longhi A, Ferrari S, Bertoni F, Versari M, Picci P (2005) Grade of chemotherapy-induced necrosis as a predictor of local and systemic control in 881 patients with non-metastatic osteosarcoma of the extremities treated with neoadjuvant chemotherapy in a single institution. Eur J Cancer 41:2079\u20132085","journal-title":"Eur J Cancer"},{"key":"1259_CR24","first-page":"883","volume":"8","author":"G Bacci","year":"2001","unstructured":"Bacci G, Ferrari S, Longhi A, Forni C, Giacomini S, Lari S, Versari M (2001) Relationship between dose-intensity of treatment and outcome for patients with osteosarcoma of the extremity treated with neoadjuvant chemotherapy. Oncol Rep 8:883\u2013888","journal-title":"Oncol Rep"},{"key":"1259_CR25","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1200\/JCO.1998.16.7.2452","volume":"16","author":"PA Meyers","year":"1998","unstructured":"Meyers PA, Gorlick R, Heller G, Casper E, Lane J, Huvos AG, Healey JH (1998) Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 16:2452\u20132458","journal-title":"J Clin Oncol"},{"key":"1259_CR26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jnci\/djk015","volume":"99","author":"IJ Lewis","year":"2007","unstructured":"Lewis IJ, Nooij MA, Whelan J, Sydes MR, Grimer R, Hogendoorn PC, Memon MA, Weeden S, Uscinska BM, van Glabbeke M, Kirkpatrick A, Hauben EI, Craft AW (2007) Taminiau AH; MRC BO06 and EORTC 80931 collaborators; European Osteosarcoma Intergroup. Improvement of histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomised phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 99:112\u2013128","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1259-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-010-1259-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-010-1259-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T22:22:54Z","timestamp":1590618174000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-010-1259-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2,13]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["1259"],"URL":"https:\/\/doi.org\/10.1007\/s00280-010-1259-3","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2,13]]}}}